Clariant, the Swiss chemicals company, announced a decline in third-quarter sales due to weak demand in its additives business. However, the company remains confident in achieving its 2023 guidance.
Sales Performance
In the third quarter, Clariant recorded quarterly sales of 1.03 billion Swiss francs ($1.14 billion), marking a 21% decrease compared to the same period last year when the sales were CHF1.31 billion. Meanwhile, the earnings before interest taxes, depreciation, and amortization (EBITDA) amounted to CHF159 million, reflecting a 28% decline from the previous year. The EBITDA margin was recorded at 15.4%, down from 16.8% in the previous year.
These results are slightly lower than the anticipated CHF1.05 billion in sales and CHF145 million in EBITDA, as projected by industry analysts.
Additives Business Challenges
Clariant's additives business faced ongoing destocking throughout the third quarter, and its volumes and pricing were negatively affected by weak demand in various end markets. As a consequence, the business saw a significant drop in both EBITDA (62%) and sales (24%) across all geographical regions.
Care Chemicals Business
The care chemicals business of Clariant also experienced challenges, with a decline of 28% in sales and 37% in EBITDA.
Outlook and Future Projections
Despite the prevailing economic uncertainties, Clariant expects to see an easing of inflation while not anticipating a complete economic recovery in the final quarter of the year. Nonetheless, the company remains optimistic about achieving its previously stated 2023 sales targets. Clariant aims for sales figures between CHF4.55 billion and CHF4.65 billion, along with an EBITDA range of CHF650 million to CHF700 million.
Our Latest News
SFC Energy Reports Strong Growth in Profit and Revenue
SFC Energy, the German fuel-cell specialist, reports significant growth in profit and revenue driven by sales growth in Asia and North America. The company is o...
Orange Confirms Solid Performance in Q3 2023
Orange releases Q3 2023 financial results with a 1.6% increase in revenue and improved EBITDA AL. Outlook remains positive for the company.
Mixed Results Expected as U.S. Stock Markets Set to Open
The U.S. stock markets are set to open with mixed results, with some promising gains in pre-market trading for certain companies, while others are experiencing...